6 hasil untuk "Muhammad, Al Azhar"
Menampilkan 1–6 · 0,42 detik · RSS
-
Artikel Jurnal
Enhancing Pediatric Cancer Survival in Indonesia: The Role of CAR T Cell Therapy
…and children diagnosed with refractory B-ALL [4]. A study by Maude et al. [5] reported high remission rates and durable responses in young adults and children with refractory or relapsed B-ALL treated with CAR T cells. Similarly, Park et al. [6] demonstrated long-term remissions and improved…
-
Artikel Jurnal
Profile of PD-L1 mRNA Expression in Childhood Acute Leukemia
Background: Programmed Death Ligand 1 (PD-L1) expression was used to determine type of patients who respond to immunotherapy using immune checkpoint inhibitor in several solid malignancies. However, the role of PD-L1 in hematological malignancies is less explored. Therefore, we aim to investigate…
-
Artikel Jurnal Teks lengkap
Influence of Single Nucleotide Polymorphism of ENPP1 and ADIPOQ on Insulin Resistance and Obesity: A Case-Control Study in a Javanese Population
Single nucleotide polymorphisms (SNPs) in obesity-related genes, such as ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) and adiponectin (ADIPOQ), potentially increase the risk of insulin resistance, the most common metabolic dysregulation related to obesity. We investigated the…
-
Artikel Jurnal
The mRNA Expression Profile of PD-1 and PD-L1 in Peripheral Blood of Colorectal Cancer Patients
Background: Immunotherapy using immune checkpoint inhibitors has currently emerged as an effective treatment for a subset of colorectal cancer (CRC) patients. The roles of PD-1 and PD-L1 expression levels in peripheral blood to predict patient’s response to immune checkpoint inhibitors are not well…
-
Artikel Jurnal
PD-L1 copy number loss is associated with lower survival in women with advanced breast cancer in Indonesian cohort
Abstract Background The prognostic value of PD-L1 copy number variation (CNV) in advanced breast cancer (BC) patients remains unclear. This study investigated the association between PD-L1 CNV and its prognostic significance in advanced BC. Methods PD-L1 CNV was analyzed using real-time PCR in…
-
Artikel Jurnal
Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparibResearch in context
Summary: Background: Loss of heterozygosity (LOH) diminishes genetic diversity within cancer genomes. A tumour arising in an individual heterozygous for a functional and a loss-of-function (LoF) allele of a gene occasionally retain only the LoF allele. This can result in deficiency of specific…